Toth Financial Advisory Corp cut its holdings in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 24.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,656 shares of the exchange traded fund’s stock after selling 2,799 shares during the quarter. Toth Financial Advisory Corp’s holdings in ProShares Ultra Nasdaq Biotechnology were worth $439,000 at the end of the most recent quarter.
Separately, Jane Street Group LLC raised its stake in shares of ProShares Ultra Nasdaq Biotechnology by 8.4% in the third quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock worth $306,000 after purchasing an additional 374 shares during the last quarter.
ProShares Ultra Nasdaq Biotechnology Stock Down 1.2 %
Shares of NASDAQ:BIB opened at $54.49 on Friday. ProShares Ultra Nasdaq Biotechnology has a 1 year low of $47.19 and a 1 year high of $69.56. The stock’s fifty day moving average price is $54.09 and its 200-day moving average price is $60.71.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
ProShares Ultra Nasdaq Biotechnology Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
See Also
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Bloom Energy: Powering the Future With Decentralized Energy
- Dividend Capture Strategy: What You Need to Know
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Invest in the FAANG Stocks
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report).
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
